NKED20 · 6 credits · Advanced level (A1N) · Teknisk biologi, Kemisk biologi
Drug Discovery and Pharmaceutical Development
Active · next start VT 2027
94%
passed the latest ordinary exam
TEN1 · 3 Jun 2026 · 53 students
98%
passed the ordinary exams, all sittings over the last 5 years
TEN1 · 286 students
18%
Harder than 18% of courses at advanced level
Compared with 285 courses at the same level, ordinary exams over the last three academic years. 113 students.
Part of 4 programmes
Exam
TEN1 Written examination
- 5
- 4
- 3
- U
Ordinary exams
98% passed · 286 students
- 94%53
- 98%60
- 100%55
- 100%59
- 98%59
Re-exams
No sittings with at least 5 students.
- Get 4 or 5: 88% (286 students)
Show small sittings (9)
Sittings with fewer than 5 students, often credit transfers or special sittings. They are not part of any figure on this page.
- 67%3
- 100%1
- 100%1
- 100%1
- 100%1
- 100%1
- 100%1
- 100%1
- 50%2
Other modules
Partial exams, hand-ins and labs. They are not part of the figures at the top.
Hand-in or lab
LAB1 Laboratory work
- G
- U
Main rounds
99% passed · 300 students
- 98%57
- 100%62
- 100%58
- 98%60
- 98%63
Later rounds
No sittings with at least 5 students.
Hand-in or lab
UPG1 Group assignments including written and oral presentations
- G
- U
Main rounds
99% passed · 300 students
- 98%57
- 100%62
- 100%58
- 98%60
- 98%63
Later rounds
No sittings with at least 5 students.
About the course
Aim
The course will provide knowledge about the different processes involved when going from discovery to approval of a pharmaceutical. After completing this course the student should be able to:
- understand the principles of the drug discovery and development process
- realize the principles of pharmaceutical mode of action and classification
- know major pharmaceutical groups and clinical uses in selected areas
- apply pharmacological methodology
- understand the basics of pharmacokinetics
- analyze various types of drugs specific conditions from production to use
Content
Overview of the drug discovery and pharmaceutical development process Pharmacodynamics: pharmaceutical molecular / cellular mechanisms of actions towards membrane proteins (receptors, ion channels) and intracellular proteins (transcription factors, enzymes), and various forms of receptor agonism and antagonism.
Pharmacokinetics: drug absorption, distribution and elimination. Laboratory workshop including computer simulations. Drug development: pre-clinical/clinical phases and drug regulatory regulations.
Major drug groups, such as small molecules and biopharmaceuticals, and their clinical use in treating cancer, cardiovascular diseases, stroke and neurodegenerative diseases, as well as a presentation of chemotherapy, antibiotics and anti-inflammatory drugs.
Critical evaluation of scientific paper with focus on research methodology.
- Examiner
- Peter Nilsson
- Scheduled hours
- 48 h
- Main field of study
- Teknisk biologi, Kemisk biologi